Innovation in the specialty chemicals industry is increasingly constrained by shortened product life cycles, rising regulatory complexity, and strong dependencies on critical functional components. When essential inputs become unavailable, companies must rapidly develop substitutes while maintaining performance, scalability, compliance, and economic viability. This article presents an anonymized industrial case study showing how additive and formulation development under severe time pressure can be accelerated through parallelized development structures and modular platform strategies. Focusing on process architecture and managerial decision-making rather than technical specifics, the contribution derives practical insights for innovation managers in process-oriented industries. Project risk is shown to be strongly influenced by early parallel R&D resource allocation rather than by capital investment decisions alone, highlighting the importance of development process architecture under severe time pressure.
Heiko Brunner (Thu,) studied this question.